AT-Patch (ATP-C130/ATP-C70) vs FFRangio System
AI Verdict
Choose AT-Patch (ATP-C130/ATP-C70) if…
Choose AT-Patch if you require extended, non-invasive ambulatory ECG monitoring for up to 14 days to detect intermittent arrhythmias. This tool is ideal for patients needing a comfortable, shower-proof device that allows them to maintain daily activities while providing continuous, AI-powered cardiac data for comprehensive analysis.
View AT-Patch (ATP-C130/ATP-C70) →Choose FFRangio System if…
Choose the FFRangio System if you are performing percutaneous coronary intervention (PCI) and require real-time, wire-free, and drug-free functional assessment of coronary artery disease. This system is best suited for cardiologists seeking to optimize PCI decisions, assess lesion impact, and confirm treatment outcomes non-invasively within the cath lab environment.
View FFRangio System →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | AT-Patch (ATP-C130/ATP-C70) | FFRangio System |
|---|---|---|
| Pricing | N/a | Contact vendor for pricing information. |
| Deployment | Wearable device for patients; analysis software deployed on-premise at medical institutions. | SaaS, on-prem, hybrid |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
AT-Patch (ATP-C130/ATP-C70)AT-Patch is designed for patient comfort and ease of use over an extended period, featuring a compact, lightweight, shower-proof design with no need for charging or electrode replacement during monitoring. The accompanying smartphone app for live ECG viewing and symptom recording further enhances patient usability and engagement.
Clinical Value
FFRangio SystemThe FFRangio System offers a transformative approach to coronary physiology by providing wire-free and drug-free 3D FFR guidance, eliminating invasive pressure wires and optimizing PCI decisions. This represents a significant advancement in interventional cardiology, potentially improving patient outcomes and procedural efficiency.
Pricing & Value
TieBoth tools explicitly state that pricing is not publicly available and requires direct contact for details. Without any comparative pricing information, it is impossible to determine which offers superior value from a cost perspective.
Enterprise Readiness
FFRangio SystemBoth tools are FDA-cleared and deployed on-premise within medical institutions. However, the FFRangio System explicitly highlights ISO 27001 certification for information security, providing a stronger, verifiable assurance of its readiness to handle sensitive data within an enterprise environment.
Innovation
FFRangio SystemWhile AT-Patch offers innovative long-term wearable monitoring with AI, the FFRangio System presents a more disruptive innovation by fundamentally changing the FFR measurement process. Its wire-free and drug-free approach, providing comprehensive functional assessment from angiography alone, represents a significant paradigm shift in interventional cardiology.
Support & Docs
AT-Patch (ATP-C130/ATP-C70)AT-Patch provides more accessible public documentation, including user manuals, and a dedicated support section on its corporate website with FAQs and contact information. While FFRangio offers an 'Instructions For Use (IFU)' that requires a request, and mentions training for new users, its public-facing documentation and support resources are less readily discoverable.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | AT-Patch (ATP-C130/ATP-C70) | FFRangio System |
|---|---|---|
| Name | AT-Patch (ATP-C130/ATP-C70) | FFRangio System |
| Company | ATsens Co. | CathWorks |
| Primary Function | Ambulatory ECG Monitor for Continuous Cardiac Monitoring | Wire-free and drug-free 3D FFR guidance for PCI decisions |
| Key Technology/Methodology | Continuous ECG monitoring with high-performance sensor chip and short-length electrode. | Real-time FFRangio values at every point on the coronary tree, simulated pullback curve, lesion impact feature. |
| AI/ML for Analysis | AT-Report software with AI/machine learning algorithms for ECG analysis | Artificial intelligence aids in quick angiogram analysis |
| Specialties | Cardiology, Family Medicine, Internal Medicine | Cardiology |
Videos
Demos, reviews, and walkthroughs featuring AT-Patch (ATP-C130/ATP-C70) and FFRangio System.